- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05173870
Remote Monitoring to Prevent Frailty Progression in the Elderly
Wearable Device Remote Monitoring to Prevent Frailty Progression in Elderly: a Pilot Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Frailty is a condition of increased vulnerability to stressors due to age-related declines in physiologic reserves across neuromuscular, metabolic, and immune systems. It is considered a medical geriatric syndrome with multiple causes and contributors and it is characterized by diminished strength, power and endurance. In general, therefore, frailty is considered to be a multifactorial dysfunctional framework which includes the physical, psychological, cognitive, economic and social spheres and which leads to a serious deterioration in the quality of life. Due to the great impact of this condition on quality of life, developing interventions programs aiming to prevent the progression of frailty towards the independence loss, it is considered a key objective to support an healthy ageing.
In this context, the primary aim of the present pilot study is to standardize a study protocol to develop a useful model to enhance local care in small population isolates, by remotely monitoring the health status of pre-frail subjects and to improve the progression of the frailty condition, in order to support a healthy ageing for future investigation including a larger number of individuals.
Additional aims:
- To quantify the timeframes necessary for the subjects recruiting and examination activities,including questionnaires and functional tests administration;
- To quantify the training time needed to explain the use of the wearable device to the recruited elderly individuals;
- To assess the responsiveness of pre-frail subjects, during the preliminary screening, the examination visit and the monitoring period (follow-up 6 months);
- To evaluate the compliance of pre-frail individuals with the use of the wearable device.
All men and women aged >= 65 years, resident a small mountain village (Salcito) in Molise region, Italy, will be invited to participate at the first examination, in order to evaluate their frailty condition, in a specific way their pre-frail/frail condition.
In the screening phase, in particular, it will be used the AGILE score to select the subjects to be included in the study. The questionnaire is a frailty tool that allows to quickly identify elderly, but also to investigate "multidimensional" frailty. It is built by selecting among the 40 items of the italian frailty index, the 10 ones most predictive of mortality. Therefore the questionnaire is composed by 10 items with a dychotomous answer (yes/no), in order to homogenously represent the four domains of frailty: physical, mental, nutrirional and socio-economic. After the preliminary screening, 30 elderly with pre-frailty will be randomly selected to be equipped with the wearable devices (such as smartband and smart-clothes ).The wearable devices have a biosensor able to daily collect,in a remote way, many biometric measurements such as: blood pressure, body temperature, heart and respiratory rate, posture and sleep quality.
During the baseline visit, the 30 pre-frail elderly will be trained to the use of the wearable devices. In addition, others questionnaires will be administered to collect information on their dietary habits, lifestyles, cognitive assessment and clinical history of the major chronic disease (CVD, cancer…). Additionally, during the baseline visit of recruited 30 pre-frail subjects, a venous blood sample will be collected. This will be used to measure biochemical and molecular parameters. In particular, samples will be analyzed to study potential biomarkers of pre-frailty/frailty condition. An aliquot of the biological sample will be stored in liquid nitrogen in a dedicated biobank of IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) NEUROMED, for any future molecular analysis.
Thanks to the wearable devices, individuals will be monitored constantly for six months, from a health point of view.
In the early stages of recruitment it will be possible to identify any critical issues in the training procedures of individuals over 65 recruited to use the wearable device.
During the six months period of monitoring, it will be possible to evaluate the compliance of subjects recruited to the wearable device use. In particular, it could be possible to evaluate the reliability of collected data thanks to the device and eventually make changes in operative procedures, when needed. If, during the monitoring, an abnormal parameter value will be observed, it will be communicated both to the subject and to his physician, with the aim of promoting a greater attention to personal health. In this way it could be possible to ensure a better quality of life. During six months, participants will be called back every other month, in order to evaluate the status of devices. After six months, participants will be called back for a follow-up visit, during which all the test, the questionnaires and the blood sample collection will be repeated to evaluate the potential impact of monitoring, on their condition.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Licia Iacoviello, MD, PhD
- Phone Number: +390865915247
- Email: licia.iacoviello@moli-sani.org; licia.iacoviello@neuromed.it
Study Contact Backup
- Name: Simona Costanzo, PhD
- Phone Number: +390865915244
- Email: simona.costanzo@neuromed.it
Study Locations
-
-
IS
-
Pozzilli, IS, Italy, 86077
- Recruiting
- IRCCS Neuromed
-
Contact:
- Roberta Parisi, BSc
-
Pozzilli, IS, Italy, 86077
- Not yet recruiting
- IRCCS INM Neuromed, Department of Epidemiology and Prevention
-
Contact:
- Licia Iacoviello, MD, PhD
- Email: licia.iacoviello@neuromed.it
-
Principal Investigator:
- Licia Iacoviello, MD, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Diagnosis of Pre-Frail;
- Salcito (a small mountain village in Molise region) residents.
Exclusion Criteria:
- Age< 65 years;
- Individuals affected by physical or mental diseases, pacemaker or other medical device keeper who make the use of "wearable device" not possible or unable to complete functional tests.
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Study protocol assessment
Time Frame: From February 2022 to August 2023
|
To standardize a study protocol to develop a useful model for enhancing local care in small population isolates, by remotely monitoring the health status of pre-frail subjects and improving the progression of the frailty condition in order to support a healthy ageing for future investigation including a larger number of individuals.
|
From February 2022 to August 2023
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Recruitment phase
Time Frame: From February 2022 to May 2022
|
This pilot study will be performed to quantify the timeframes necessary for the recruitment of the elderly subjects and for the examination activities, including questionnaires and functional tests administration.
|
From February 2022 to May 2022
|
Training Phase
Time Frame: From February 2022 to May 2022
|
This pilot study will be performed to quantify the training time needed to explain the use the wearable device to the recruited elderly individuals.
|
From February 2022 to May 2022
|
Pre-frail subjects responsiveness
Time Frame: From February 2022 to August 2022
|
This pilot study want to assess the responsiveness (i.e.the active participation to the project) of pre-frail subjects. This aspect will be evaluated as follows:
|
From February 2022 to August 2022
|
Wearable device compliance
Time Frame: From February 2022 to August 2022
|
This pilot study want to evaluate the compliance of pre-frail individuals with the use of the wearable device. This aspect will be evaluated by monitoring the time during which subjects wear the device. If it is weared less than 5 days (20/24h) per week, it will be considered as a low compliance. |
From February 2022 to August 2022
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Licia Iacoviello, MD, PhD, IRCCS Neuromed
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DEP_022021
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Frailty
-
University of PennsylvaniaCompleted
-
Instituto Tecnologico y de Estudios Superiores...Not yet recruiting
-
Longeveron Inc.CompletedAging FrailtyUnited States
-
Longeveron Inc.CompletedAging FrailtyUnited States
-
The Hong Kong Polytechnic UniversityCompleted
-
Xijing HospitalUnknownFrailty SyndromeChina
-
Region ZealandUniversity of Southern DenmarkActive, not recruitingFrailty SyndromeDenmark
-
Ankara Etlik City HospitalNot yet recruiting
-
IRCCS Centro San Giovanni di Dio FatebenefratelliCompleted
-
University of Erlangen-Nürnberg Medical SchoolCompleted
Clinical Trials on Wearable device
-
Massachusetts General HospitalCase Western Reserve UniversityRecruitingSurgery--ComplicationsUnited States
-
University of West LondonRoyal London Hospital for Integrated MedicineRecruitingMusculoskeletal Chronic Pain ConditionsUnited Kingdom
-
Istituti Clinici Scientifici Maugeri SpACompleted
-
Xuanwu Hospital, BeijingNot yet recruitingCervical Disc Herniation | Ossification of Posterior Longitudinal Ligament | Cervical Spinal Stenosis | Neckbrace Device
-
Peking University First HospitalRecruiting
-
Jing LiuHUAWEINot yet recruitingMasked HypertensionChina
-
Cardiff UniversityCardiff and Vale University Health BoardCompletedPerioperative CareUnited Kingdom
-
China-Japan Friendship HospitalNot yet recruitingHeart Failure
-
Acurable Ltd.Hospital Universitario Virgen MacarenaRecruitingObstructive Sleep ApneaSpain
-
University of Massachusetts, WorcesterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...CompletedCardiovascular Diseases | CancerUnited States